Bone morphogenetic protein-induced heterotopic bone formation: What have we learned from the history of a half century?

Japanese Dental Science Review

Volumn 51, Issue 2, 2015, Pages 42-50

  Katagiri, Takenobu ^a   Osawa, Kenji ^a   Tsukamoto, Sho ^a   Fujimoto, Mai ^a,b   Miyamoto, Arei ^a   Mizuta, Takato ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

BMP; Bone formation; Differentiation; Receptor; Signal transduction; Skeletal muscle

Indexed keywords

EID: 84925303034     PISSN: 18827616     EISSN: 22136851     Source Type: Journal    
DOI: 10.1016/j.jdsr.2014.09.004     Document Type: Review

References (80)

1. Katagiri T., Suda T., Miyazozo K. The bone morphogenetic proteins. The TGF-β family 2008, 121-149. Cold Spring Harbor Press, New York. K. Miyazono, R. Derynck (Eds.).
2. Miyazono K., Kamiya Y., Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem 2010, 147:35-51.
3. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
4. Huggins C., Wiseman S., Reddi A.H. Transformation of fibroblasts by allogeneic and xenogeneic transplants of demineralized tooth and bone. J Exp Med 1970, 132:1250-1258.
5. Urist M.R., Mikulski A.J. A soluble bone morphogenetic protein extracted from bone matrix with a mixed aqueous and nonaqueous solvent. Proc Soc Exp Biol Med 1979, 162:48-53.
6. Urist M.R., Mikulski A., Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci U S A 1979, 76:1828-1832.
7. Nogami H., Urist M.R. Transmembrane bone matrix gelatin-induced differentiation of bone. Calcif Tissue Res 1975, 19:153-163.
8. Sampath T.K., Reddi A.H. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci U S A 1981, 78:7599-7603.
9. Katz R.W., Reddi A.H. Dissociative extraction and partial purification of osteogenin, a bone inductive protein, from rat tooth matrix by heparin affinity chromatography. Biochem Biophys Res Commun 1988, 157:1253-1257.
10. Wang E.A., Rosen V., Cordes P., Hewick R.M., Kriz M.J., Luxenberg D.P., et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A 1988, 85:9484-9488.
11. Nogami H., Urist M.R. Substrata prepared from bone matrix for chondrogenesis in tissue culture. J Cell Biol 1974, 62:510-519.
12. Sampath T.K., Nathanson M.A., Reddi A.H. In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone. Proc Natl Acad Sci U S A 1984, 81:3419-3423.
13. Seyedin S.M., Thomas T.C., Thompson A.Y., Rosen D.M., Piez K.A. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci U S A 1985, 82:2267-2271.
14. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
15. Luyten F.P., Cunningham N.S., Ma S., Muthukumaran N., Hammonds R.G., Nevins W.B., et al. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 1989, 264:13377-13380.
16. Sampath T.K., Coughlin J.E., Whetstone R.M., Banach D., Corbett C., Ridge R.J., et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem 1990, 265:13198-13205.
17. Celeste A.J., Iannazzi J.A., Taylor R.C., Hewick R.M., Rosen V., Wang E.A., et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 1990, 87:9843-9847.
18. Ozkaynak E., Rueger D.C., Drier E.A., Corbett C., Ridge R.J., Sampath T.K., et al. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 1990, 9:2085-2093.
19. Wang E.A., Rosen V., D'Alessandro J.S., Bauduy M., Cordes P., Harada T., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 1990, 87:2220-2224.
20. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992, 267:20352-20362.
21. Sampath T.K., Rashka K.E., Doctor J.S., Tucker R.F., Hoffmann F.M. Drosophila transforming growth factor beta superfamily proteins induce endochondral bone formation in mammals. Proc Natl Acad Sci U S A 1993, 90:6004-6008.
22. Shimmi O., Ralston A., Blair S.S., O'Connor M.B. The crossveinless gene encodes a new member of the Twisted gastrulation family of BMP-binding proteins which, with Short gastrulation, promotes BMP signaling in the crossveins of the Drosophila wing. Dev Biol 2005, 282:70-83.
23. Cheng H., Jiang W., Phillips F.M., Haydon R.C., Peng Y., Zhou L., et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003, 85-A:1544-1552.
24. Kang Q., Sun M.H., Cheng H., Peng Y., Montag A.G., Deyrup A.T., et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004, 11:1312-1320.
25. Seyedin S.M., Thompson A.Y., Bentz H., Rosen D.M., McPherson J.M., Conti A., et al. Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem 1986, 261:5693-5695.
26. Sampath T.K., Muthukumaran N., Reddi A.H. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci U S A 1987, 84:7109-7113.
27. Bentz H., Thompson A.Y., Armstrong R., Chang R.J., Piez K.A., Rosen D.M. Transforming growth factor-beta 2 enhances the osteoinductive activity of a bovine bone-derived fraction containing bone morphogenetic protein-2 and 3. Matrix 1991, 11:269-275.
28. Ogawa Y., Schmidt D.K., Nathan R.M., Armstrong R.M., Miller K.L., Sawamura S.J., et al. Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation. J Biol Chem 1992, 267:14233-14237.
29. Tachi K., Takami M., Sato H., Mochizuki A., Zhao B., Miyamoto Y., et al. Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-beta1. Tissue Eng A 2011, 17:597-606.
30. Bentz H., Nathan R.M., Rosen D.M., Armstrong R.M., Thompson A.Y., Segarini P.R., et al. Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem 1989, 264:20805-20810.
31. Bentz H., Chang R.J., Thompson A.Y., Glaser C.B., Rosen D.M. Amino acid sequence of bovine osteoinductive factor. J Biol Chem 1990, 265:5024-5029.
32. Katagiri T., Yamaguchi A., Ikeda T., Yoshiki S., Wozney J.M., Rosen V., et al. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 1990, 172:295-299.
33. Taylor S.M., Jones P.A. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 1979, 17:771-779.
34. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
35. Yamaguchi A., Katagiri T., Ikeda T., Wozney J.M., Rosen V., Wang E.A., et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991, 113:681-687.
36. Blau H.M., Chiu C.P., Webster C. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 1983, 32:1171-1180.
37. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127:1755-1766.
38. Katagiri T., Tsukamoto S. The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway. Biol Chem 2013, 394:703-714.
39. Wieser R., Wrana J.L., Massague J. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J 1995, 14:2199-2208.
40. Namiki M., Akiyama S., Katagiri T., Suzuki A., Ueno N., Yamaji N., et al. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem 1997, 272:22046-22052.
41. Onichtchouk D., Chen Y.G., Dosch R., Gawantka V., Delius H., Massague J., et al. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 1999, 401:480-485.
42. Akiyama S., Katagiri T., Namiki M., Yamaji N., Yamamoto N., Miyama K., et al. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. Exp Cell Res 1997, 235:362-369.
43. Aoki H., Fujii M., Imamura T., Yagi K., Takehara K., Kato M., et al. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci 2001, 114:1483-1489.
44. Fukuda T., Kohda M., Kanomata K., Nojima J., Nakamura A., Kamizono J., et al. Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem 2009, 284:7149-7156.
45. Savage C., Das P., Finelli A.L., Townsend S.R., Sun C.Y., Baird S.E., et al. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components. Proc Natl Acad Sci U S A 1996, 93:790-794.
46. Raftery L.A., Twombly V., Wharton K., Gelbart W.M. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics 1995, 139:241-254.
47. Katagiri T. Heterotopic bone formation induced by bone morphogenetic protein signaling: fibrodysplasia ossificans progressiva. J Oral Biosci 2010, 52:33-41.
48. Nojima J., Kanomata K., Takada Y., Fukuda T., Kokabu S., Ohte S., et al. Dual roles of Smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J Biol Chem 2010, 285:15577-15586.
49. Lin X., Duan X., Liang Y.Y., Su Y., Wrighton K.H., Long J., et al. PPM1A functions as a Smad phosphatase to terminate TGFb signaling. Cell 2006, 125:915-928.
50. Duan X., Liang Y.Y., Feng X.H., Lin X. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem 2006, 281:36526-36532.
51. Knockaert M., Sapkota G., Alarcon C., Massague J., Brivanlou A.H. Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci U S A 2006, 103:11940-11945.
52. Sapkota G., Knockaert M., Alarcon C., Montalvo E., Brivanlou A.H., Massague J. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. J Biol Chem 2006, 281:40412-40419.
53. Kokabu S., Nojima J., Kanomata K., Ohte S., Yoda T., Fukuda T., et al. Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation. J Bone Miner Res 2010, 25:653-660.
54. Kokabu S., Ohte S., Sasanuma H., Shin M., Yoneyama K., Murata E., et al. Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase. Mol Endocrinol 2011, 25:474-481.
55. Kodaira K., Imada M., Goto M., Tomoyasu A., Fukuda T., Kamijo R., et al. Purification and identification of a BMP-like factor from bovine serum. Biochem Biophys Res Commun 2006, 345:1224-1231.
56. David L., Mallet C., Keramidas M., Lamande N., Gasc J.M., Dupuis-Girod S., et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 2008, 102:914-922.
57. Benezra R., Davis R.L., Lassar A., Tapscott S., Thayer M., Lockshon D., et al. Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Ann N Y Acad Sci 1990, 599:1-11.
58. Jen Y., Weintraub H., Benezra R. Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev 1992, 6:1466-1479.
59. Katagiri T., Imada M., Yanai T., Suda T., Takahashi N., Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 2002, 7:949-960.
60. Nakahiro T., Kurooka H., Mori K., Sano K., Yokota Y. Identification of BMP-responsive elements in the mouse Id2 gene. Biochem Biophys Res Commun 2010, 399:416-421.
61. Shepherd T.G., Theriault B.L., Nachtigal M.W. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. Gene 2008, 414:95-105.
62. Shin M., Ohte S., Fukuda T., Sasanuma H., Yoneyama K., Kokabu S., et al. Identification of a novel bone morphogenetic protein (BMP)-inducible transcript, BMP-inducible transcript-1, by utilizing the conserved BMP-responsive elements in the Id genes. J Bone Miner Metab 2013, 31:34-43.
63. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
64. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
65. Kaplan F.S., Tabas J.A., Zasloff M.A. Fibrodysplasia ossificans progressiva: a clue from the fly?. Calcif Tissue Int 1990, 47:117-125.
66. Pignolo R.J., Shore E.M., Kaplan F.S. Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatr Endocrinol Rev 2013, 10(Suppl. 2):437-448.
67. Shore E.M., Xu M., Feldman G.J., Fenstermacher D.A., Cho T.J., Choi I.H., et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006, 38:525-527.
68. Katagiri T. Recent topics in fibrodysplasia ossificans progressiva. J Oral Biosci 2012, 54:119-123.
69. Fukuda T., Kanomata K., Nojima J., Kokabu S., Akita M., Ikebuchi K., et al. A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. Biochem Biophys Res Commun 2008, 377:905-909.
70. Ohte S., Shin M., Sasanuma H., Yoneyama K., Akita M., Ikebuchi K., et al. A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H. Biochem Biophys Res Commun 2011, 407:213-218.
71. Shen Q., Little S.C., Xu M., Haupt J., Ast C., Katagiri T., et al. The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest 2009, 119:3462-3472.
72. Groppe J.C., Wu J., Shore E.M., Kaplan F.S. In vitro analyses of the dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP. Cells Tissues Organs 2011, 194:291-295.
73. Yu P.B., Deng D.Y., Lai C.S., Hong C.C., Cuny G.D., Bouxsein M.L., et al. BMP type I receptor inhibition reduces heterotopic ossification. Nat Med 2008, 14:1363-1369.
74. Lounev V.Y., Ramachandran R., Wosczyna M.N., Yamamoto M., Maidment A.D., Shore E.M., et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 2009, 91:652-663.
75. Medici D., Shore E.M., Lounev V.Y., Kaplan F.S., Kalluri R., Olsen B.R. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010, 16:1400-1406.
76. Wosczyna M.N., Biswas A.A., Cogswell C.A., Goldhamer D.J. Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res 2012, 27:1004-1017.
77. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
78. Rebbapragada A., Benchabane H., Wrana J.L., Celeste A.J., Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol 2003, 23:7230-7242.
79. Sartori R., Schirwis E., Blaauw B., Bortolanza S., Zhao J., Enzo E., et al. BMP signaling controls muscle mass. Nat Genet 2013, 45:1309-1318.
80. Winbanks C.E., Chen J.L., Qian H., Liu Y., Bernardo B.C., Beyer C., et al. The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J Cell Biol 2013, 203:345-357.